Garrett Pohlman, MD
Urology · Kearney, NENPI 1437378171
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $107,633 of the $122,606 with a category attached, or 87.8%. 40 manufacturers reported payments, led by Laborie Medical Technologies Corp. at 48.9% of the total. 2025 is the largest year on record at $54,114, more than ten times the $1,161 reported in 2019. Among urology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 238 payments — averaging $515.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Laborie Medical Technologies Corp.$60K
- Procept Biorobotics Corporation$39K
- SWAN Valley Medical Incorporated$10K
- Intuitive Surgical$4K
- Olympus America Inc.$3K
- Telix Pharmaceuticals$2K
- plus $5K from 34 others
Across 3 payments — averaging $0.00 each. An ownership or investment interest held by the physician or an immediate family member.
- SWAN Valley Medical Incorporated$0
What the payments were for
- Consulting fees$107,63388%
- Speaking & faculty fees$1,0001%
- Travel & lodging$5,0854%
- Food & beverage$4,8734%
- Education$4,0153%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Laborie Medical Technologies Corp. | 32 | $59,994 |
| Procept Biorobotics Corporation | 37 | $38,630 |
| SWAN Valley Medical Incorporated | 3 | $9,702 |
| Intuitive Surgical | 4 | $4,469 |
| Olympus America Inc. | 5 | $3,054 |
| Telix Pharmaceuticals | 8 | $2,069 |
| Teleflex LLC | 18 | $1,365 |
| Neotract Inc. | 8 | $869 |
| AbbVie(2 entities) | 17 | $264 |
| Verity Pharmaceuticals Inc. | 10 | $207 |
| Johnson & Johnson | 10 | $165 |
| Boston Scientific | 7 | $150 |
| Bioprotect Medical, Inc. | 3 | $141 |
| Astellas Pharma US Inc | 8 | $124 |
| Dendreon Pharmaceuticals LLC | 6 | $112 |
| Novartis | 5 | $112 |
| Pfizer | 7 | $108 |
| Urogen Pharma, Inc. | 5 | $103 |
| Medtronic(2 entities) | 2 | $88 |
| Kerecis Limited | 3 | $79 |
| EDAP Technomed Inc | 3 | $65 |
| Innovation Technologies Inc | 2 | $62 |
| Endo Pharmaceuticals Inc. | 4 | $58 |
| Merck | 3 | $57 |
| Myovant Sciences Inc. | 4 | $56 |
| Tolmar, Inc. | 2 | $50 |
| BD | 1 | $49 |
| Coloplast | 3 | $45 |
| Axonics, Inc. | 2 | $42 |
| Bayer | 2 | $39 |
| KARL Storz Endoscopy-america | 2 | $39 |
| Amgen | 2 | $38 |
| Calyxo, Inc. | 2 | $37 |
| Tolmar Pharmaceuticals, Inc. | 2 | $31 |
| Angiodynamics, Inc. | 1 | $31 |
| Cardinal Health 414 LLC | 1 | $28 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Conmed Corporation | 1 | $19 |
| Rochester Medical Corporation | 1 | $18 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Optilume BPH Drug Coated Balloon Catheter$59,729
- AquaBeam Robotic System$21,205
- AQUABEAM SYSTEM$17,000
- Da Vinci Surgical System$4,463
- iTIND System$3,000
- ILLUCCIX$1,948
- UroLift System$1,000
- UroLift$711
How this compares
$122,606 in reported general payments places this provider in the 95th percentile of 79 urology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 142 | $69,260 |
| GemtesaVibegron | 64 | $23,557 |
| Solifenacin Succinate | 167 | $4,449 |
| Oxybutynin Chloride ErOxybutynin Chloride | 55 | $1,246 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 88 | $707 |
| Tamsulosin Hcl | 78 | $541 |
| Cephalexin | 37 | $525 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $244 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $209 |
| Finasteride | 20 | $199 |
| Fluconazole | 17 | $145 |
| Megestrol Acetate | 13 | $145 |
| Levofloxacin | 45 | $143 |
| Oxybutynin Chloride | 13 | $104 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $124 | $69,260142 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 79 urology providers in Nebraska.
Other urology in Kearney
- Laroy WilliamsKearney$6K
- Scott HoweKearney$3K
- John BishayOmaha$138K
- Rebecca McCreryOmaha$71K
- Judson DaviesOmaha$67K
- Stefanie BolteOmaha$59K
- Antonio BeltranLincoln$51K
- Michael FeloneyOmaha$29K
- Ansar KhanFremont$15K
- Don HensleeFairbury$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.